Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Flórez

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Neuroscience|June 5, 2002
Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonismA Díaz, A Pazos, J Flórez, et al.
Brain Research|February 28, 1997
Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndromeM Dierssen, I F Vallina, C Baamonde, et al.
Stress (Amsterdam, Netherlands)|August 21, 2002
Postnatal handling induces long-term modifications in central beta-noradrenergic signalling in ratsC Baamonde, M A Lumbreras, C MartInez-Cué, et al.
Neuroreport|May 13, 1999
A murine model for Down syndrome shows reduced responsiveness to painC Martínez-Cué, C Baamonde, M A Lumbreras, et al.
Nanotechnology|March 8, 2017
Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA)J Cruz, J Flórez, R Torres, et al.
Journal of Neuroscience Research|December 18, 2001
Reduced phospholipase C-beta activity and isoform expression in the cerebellum of TS65Dn mouse: a model of Down syndromeI Ruiz de Azúa, M A Lumbreras, A Zalduegui, et al.
Neuroscience|June 26, 2012
Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndromeV Vidal, S García, P Martínez, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 21, 2003
Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichmentM Dierssen, R Benavides-Piccione, C Martínez-Cué, et al.
Amino Acids|April 4, 2006
Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's diseaseM Lumbreras, C Baamonde, C Martínez-Cué, et al.
Neuroscience|September 30, 2010
Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndromeM V Llorens-Martín, N Rueda, G S Tejeda, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Neuroscience|June 5, 2002
Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonismA Díaz, A Pazos, J Flórez, et al.
Brain Research|February 28, 1997
Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndromeM Dierssen, I F Vallina, C Baamonde, et al.
Stress (Amsterdam, Netherlands)|August 21, 2002
Postnatal handling induces long-term modifications in central beta-noradrenergic signalling in ratsC Baamonde, M A Lumbreras, C MartInez-Cué, et al.
Neuroreport|May 13, 1999
A murine model for Down syndrome shows reduced responsiveness to painC Martínez-Cué, C Baamonde, M A Lumbreras, et al.
Nanotechnology|March 8, 2017
Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA)J Cruz, J Flórez, R Torres, et al.
Journal of Neuroscience Research|December 18, 2001
Reduced phospholipase C-beta activity and isoform expression in the cerebellum of TS65Dn mouse: a model of Down syndromeI Ruiz de Azúa, M A Lumbreras, A Zalduegui, et al.
Neuroscience|June 26, 2012
Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndromeV Vidal, S García, P Martínez, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 21, 2003
Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichmentM Dierssen, R Benavides-Piccione, C Martínez-Cué, et al.
Amino Acids|April 4, 2006
Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's diseaseM Lumbreras, C Baamonde, C Martínez-Cué, et al.
Neuroscience|September 30, 2010
Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndromeM V Llorens-Martín, N Rueda, G S Tejeda, et al.
Pageof 6